Projects per year
- 250 - 300 out of 382 results
Search results
-
*OPEN FOR DISSEMINATION ONLY* An evaluation of the implementation of national school food standards in secondary schools and their impact on the school food environment and pupil intake of free sugars: a mixed methods study
Ravaghi, V., Sitch, A., Cheng, K., Bartington, S., Hurley, K., Adab, P., Frew, E., Pallan, M., Parry, J., Bowden, S., Bowden, S., Lax, S. & Lax, S.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/03/19 → 31/12/23
Project: Other Government Departments
-
IcICLLe: Assessment of the Mechanism of Action of Ibrutinib (PCI-32765) in B-cell Receptor Pathway Inhibition in CLL
Siddique, S. & Fenwick, N.
14/03/14 → 31/12/23
Project: Research
-
Risk-stratified sequential treatment of de-novo post-transplant lymphoproliferative disorder (PTLD) with Ibrutinib and Rituximab (IR) and IR-CHOP
Craddock, C. & Jackson, A.
BLOODWISE, Janssen-Cilag Limited
1/12/15 → 31/12/23
Project: Research
-
A randomised, open-label, multicentre, Phase III trial of in vivo purging with anti-CD38 (Daratumumab) to enhance myeloma autografting (IPANEMA)
Hodgkinson, A., Siddique, S., Gates, S. & Craddock, C.
1/10/20 → 31/12/23
Project: Research
-
-
PARC: A Phase I / II study evaluating the activity of Pegylated recombinant human Arginase (BCT-100) in RElapsed/refractory Cancers of childhood
Mussai, F., Beggs, A., Fenwick, N., Wheatley, K., De Santo, C., Kearns, P. & Slade, D.
BIO-CANCER TREATMENT INTERNATIONAL LTD, INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC), Cancer Research Uk
1/12/17 → 31/03/24
Project: Research
-
-
ENDED. OPEN ONLY FOR ARCHIVING AND PUBLISHING COST.Systematic Reviews in Childrens Cancer: CNS Tumours
Wilson, J., Kearns, P. & Wheatley, K.
21/07/14 → 30/04/24
Project: Other Government Departments
-
Prevent Ductal Carcinomain Situ Invasia Overtreatment Now- PRECISION
Rea, D.
1/05/17 → 30/04/24
Project: Research
-
BIOMEDE : Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication .
1/02/16 → 30/04/24
Project: Research
-
Assessment of the Mechanism of Action of Venetoclax (ABT-199) in combination with Ibrutinib (PCI-32765) in relapsed/refractory Chronic Lymphocytic Leukaemia (CLARITY)
Brock, K. & Siddique, S.
Janssen-Cilag Limited, Abbvie Ltd, BLOODWISE
1/01/16 → 31/05/24
Project: Research
-
Clinical training Award - Cycle 4 - 2018
Kearns, P., Taylor, G. & Gough, R.
1/09/18 → 31/05/24
Project: Research
-
ADAPT SEPSIS - Biomarker-guided duration of antibiotic treatment in hospitalised patients with moderate or severe sepsis
1/05/17 → 31/07/24
Project: Other Government Departments
-
International Collaborative Treatment Protocol for Langerhans Cell Histiocytosis (LCH-IV)
1/10/12 → 31/08/24
Project: Research
-
Fluid-Gels as Resorbable Protective Dressings for Ocular Surface Disease
Slade, A., Rauz, S. & Slade, A.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/03/19 → 30/09/24
Project: Other Government Departments
-
CRISP: A phase Ib of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies (Study ITCC 053)
Fenwick, N., Kearns, P. & Seaford, E.
Cancer Research Uk, Erasmus Univesitair Medisch Centrum
1/04/18 → 31/10/24
Project: Research
-
Systematic review of published systematic reviews to assess the effectiveness of interventions to improve long-term sequelae in patients with head and neck cancer. - OPEN FOR DISSEMINATION ONLY
Wilson, J., Mehanna, H. & Moore, D.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/01/20 → 30/11/24
Project: Other Government Departments
-
Adjuvant Chemotherapy with Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Cholangiocarcinoma (ACTICCA-1 Trial)
Fox, R., Ma, Y. T. & Stubbs, C.
1/04/15 → 30/11/24
Project: Research
-
A Randomised Phase IIb Trial of BEvACizumab Added to Temozolomide + IrinOtecan for Children with Refractory/Relapsed Neuroblastoma - BEACON Trial
EUSA Pharma (UK) Limited, SOLVING KIDS' CANCER, Cancer Research Uk, INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC)
1/01/13 → 30/11/24
Project: Research
-
Cancer Research UK Birmingham Centre. See Also RCPV20624
Kearns, P., Willcox, B., Lee, S., Middleton, G., Moss, P. & Morton, D.
1/04/17 → 31/12/24
Project: Research
-
UKMCC-1 (previously PAZAM!): Pazopanib in Advanced Merkel Cell Carcinoma
Steven, N., Gaunt, P. & Wheatley, K.
Cancer Research Uk, Glaxosmithkline
1/11/12 → 31/12/24
Project: Research
-
A phase II trial of MK-3475 in patients with non-small cell lung cancer with a performance status of 2 (PePS2)
Billingham, L. & Middleton, G.
21/10/15 → 31/12/24
Project: Industry
-
A phase II trial to assess the activity of Gemtuzumab Ozogamicin Therapy in HAemophagocytic lymphohistiocytosis (HLH) or Macrophage activation syndrome (MAS) or relapsed/refractory solid tumours
De Santo, C., Kearns, P., Billingham, L., Middleton, G. & Mussai, F.
Little Princess Trust, Eveson Charitable Trust
1/01/20 → 31/12/24
Project: Research
-
A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)
Siddique, S., Jackson, A. & Craddock, C.
6/07/17 → 31/12/24
Project: Industry
-
PHAZAR/RuxAza - A phase Ib study to assess the safety and tolerability of oral Ruxolitinib in combination with 5 azacitidine in patients with accelerated phase MPNs, MDS or AML after MPNs
Siddique, S., Fox, S., Fenwick, N. & Jackson, A.
BLOODWISE, CELGENE INTERNATIONAL SARL, NOVARTIS PHARMACEUTICALS UK LTD
1/04/14 → 31/12/24
Project: Research
-
SeluDex: A phase IB/II open label study of the MEK-inhibitor selumetinib in combination with dexamethasone for paediatric and adult patients with 2nd relapsed precursor B- or T-ALL
ASTRA ZENECA UK LIMITED, INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC), Cancer Research Uk
1/10/16 → 31/12/24
Project: Research
-
ORACLE - Randomized Phase 3 Study evaluating the Efficacy and the Safety of Oral Azacitidine (CC-486) compared to Investigator’s Choice Therapy in Patient with Relapsed or Refractory Angioimmunoblastic T cell Lymphoma (ORACLE)â€,
Craddock, C.
The Lymphoma Academic Research Organisation
1/08/19 → 31/12/24
Project: Research
-
Wisteria - Wee inhibitor with Cisplatin and Radiotherapy: A trial in head and neck cancer
Kong, A., Mehanna, H., Parish, J. & Windridge, D.
ASTRA ZENECA UK LIMITED, Cancer Research Uk
1/09/15 → 31/12/24
Project: Research
-
Development of a novel repurposed drug treatment for neurodegeneration and diabetes in Wolfram syndrome
Nagy, Z., Peet, A., Brock, K., Barrett, T. & Martin, U.
1/03/17 → 28/02/25
Project: Research Councils
-
A randomised phase II study of temozolomide with or without cannabinoids in patients with recurrent glioblastoma: ARISTOCRAT
Patel, A., Billingham, L. & Savage, J.
1/02/23 → 28/02/25
Project: Research
-
CRUK/17/013 E-smart : European proof of concept therapeutic stratification trial of molecular anomalies in replapsed or refractory tumours in children(E-smart)
Kearns, P., Fenwick, N. & Gough, R.
1/11/17 → 28/02/25
Project: Research
-
Safety and efficacy of a novel anti-microbial burn wound dressing
Fletcher, P., Grover, L., Nice, L., Barton, D. & Geoghegan, J.
1/04/22 → 31/03/25
Project: Other Government Departments
-
LIBERATE-FULL- A phase IIb, randomised, double-bLInd, placeBo-controllEd tRiAl To invEstigate the safety, efficacy and mechanism of inhibiting platelet GPVI as a treatment for ST-elevation myocardial infarction
Barton, D., Thomas, M. R., Nicolson, P., Bach, S., Watson, S., Pirrie, S. & Homer, V.
1/04/22 → 31/03/25
Project: Research
-
Glo-BNHL Platform (full): [CR-UK] ACCELERATE platform study for relapsed and refractory B cell non-Hodgkin's lymphoma (B-NHL)
Billingham, L., Kearns, P., Seaford, E. & Maycock, S.
1/05/22 → 30/04/25
Project: Research
-
PACE: The impact of COVID-19 on patients with AML undergoing chemotherapy: an epidemiological study
Jackson, A., Craddock, C., Loke, J., Boucher, B. & Fox, S.
CELGENE INTERNATIONAL II SARL, BLOODWISE
1/04/20 → 30/06/25
Project: Research
-
VICTOR: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: a molecularly guided study
Billingham, L., Freeman, S. & Craddock, C.
Cancer Research Uk, Abbvie Ltd
1/02/20 → 31/07/25
Project: Research